Back to Learn
SemaglutideGuide2 min read

Ozempic, Wegovy, and Compounded Semaglutide Explained

Semaglutide is an ingredient name; Ozempic and Wegovy are branded products with specific labeling. A compounded semaglutide preparation is separate and is not an FDA-approved generic of either brand.

By PacificRx editorial team · Published

At a glance

Semaglutide is an ingredient name; Ozempic and Wegovy are branded products with specific labeling. A compounded semaglutide preparation is separate and is not an FDA-approved generic of either brand. Confirm the product, indication, and instructions rather than relying on the ingredient name alone.

  • Brand, ingredient, and compounded preparation are different terms.
  • Approval belongs to a specific product and use.
  • Ask which current Medication Guide applies.
This article is educational and is not medical advice. A licensed clinician must review your medical history before determining whether treatment is appropriate.Read our editorial standards.

Why are the names used together?

Ozempic and Wegovy are associated with semaglutide, so they often appear in the same conversation. However, a brand name identifies a particular approved product, while the ingredient name can appear in discussions of multiple formulations and uses.

The distinction matters when comparing evidence, instructions, cost, and access. A headline about a branded product does not automatically describe the product in a different advertisement or compounded prescription.

What does an FDA-approved indication mean?

An approved product has labeling for specific uses and patient populations. Semaglutide product indications have developed over time, so current labeling is the appropriate reference for a discussion about a particular brand and condition.

Ask your clinician to explain the intended use and relevant evidence for the exact product. Do not infer that every preparation using semaglutide has all the approved indications associated with the ingredient across different brands.

Why is a compounded preparation different?

Compounded drugs do not undergo FDA premarket review for safety, effectiveness, or quality. They may serve an individual medical need when appropriate and lawful, but they should not be marketed as automatically equivalent to an approved brand.

If a compounded preparation is proposed, ask for the dispensing pharmacy's identity, the formulation details, and an explanation of why it is being considered. Ask about established alternatives as part of the same discussion.

What information should I keep?

Keep the exact product name, pharmacy label, instructions, clinician's plan, and pharmacy contact details. These help the care team answer questions about a refill, a change in appearance, or a possible adverse effect.

When comparing online programs, record whether the offer names a branded product or a compounded preparation. A lower price should not erase that distinction or replace clinical evaluation.

Sources